| Literature DB >> 33986213 |
S Craig Morris1, Scott C Nelson, Lee M Zuckerman.
Abstract
Although there is literature discussing the treatment of acute and chronic trauma in austere environments, no literature or guidelines for the treatment of musculoskeletal tumors exist. This series discusses case examples with considerations and pitfalls of performing limb-salvage surgery in an underserved location. Cases of limb-salvage surgery performed by the same orthopaedic oncologist in Haiti and the Dominican Republic are discussed with a review of the literature on limb salvage for musculoskeletal tumors in developing nations. All patients successfully underwent limb-salvage surgery after considering multiple factors including tumor type and location. Patients with metastatic disease, likelihood of substantial blood loss, and poor health were not candidates for limb-salvage surgery. Medical missions and the development of partnerships with established training programs make limb salvage a greater possibility. Knowledge of the facility, anesthesia support, and instrumentation available is vital. Advanced imaging, blood products, and allograft are likely unavailable or difficult to obtain. Established continuity of care is necessary, and training of the local surgeon should be provided. Surgery should only be considered if it is safe and provides more of a benefit to the patient than an amputation.Entities:
Mesh:
Year: 2020 PMID: 33986213 PMCID: PMC7537826 DOI: 10.5435/JAAOSGlobal-D-19-00172
Source DB: PubMed Journal: J Am Acad Orthop Surg Glob Res Rev ISSN: 2474-7661
Questions and Considerations to Evaluate the Viability of Performing the Limb-Salvage Surgery
| Yes Required for Complex Limb-Salvage Surgery | Considerations |
| Has the surgeon operated there previously? | Is the country/government stable? |
| Is the surgeon able to direct postoperative care or return to the country if needed? | Can the pathology be evaluated? |
| Has the anesthesiologist worked there previously? | Is there a physical therapist? |
| Is there a local surgeon that can manage complications and follow the patient long term? | Is there a prosthetist/material to make prosthetics? |
| Will training of a local surgeon be provided? | Is the patient able to pay for testing, blood, or other costs that may not be needed with another surgery? |
| Is the required equipment available and working? | Is a local blood bank available? |
| If specialized equipment is needed, can it be brought into the country? | |
| Can the operating room handle a power outage? | |
| Is the available imaging adequate to perform the proposed surgery? | |
| Does the patient have localized disease? | |
| Will the patient survive without other treatment modalities if they are not available? | |
| Is the patient able to tolerate the expected blood loss? | |
| Is the expected functional outcome better than an amputation? | |
| Is the patient able to follow-up in-person and can be contacted by phone? | |
| Will outcomes be evaluated and improvements in care be provided? |
Figure 1AP and oblique radiographs of the distal femur showing a soft-tissue mass near the knee joint with calcifications. These characteristic findings lead to synovial sarcoma being in the differential of possible lesions. The mass was mobile and away from the neurovascular structures and a chest radiograph was normal. Therefore, limb-salvage surgery could be considered.
Figure 2Lateral radiograph of the left femur showing a lesion of the distal femur with bone formation and a sun burst pattern characteristic of osteosarcoma. Clinical photograph demonstrating associated swelling and deformity about the distal femur. Limb salvage was not chosen due to the risk of the surgery, lack of chemotherapy, and lung nodules on chest radiographs.
Figure 3Clinical photograph demonstrating a large mass at the right proximal tibia with a varus deformity.
Figure 4AP radiograph of the right knee preoperatively with recurrent giant cell tumor that was found to have undergone sarcomatous transformation. AP radiograph of the right knee after resection and reconstruction with a proximal tibial replacement.
Figure 5Clinical photograph of a 19-year-old man with a chronic draining wound of the right shoulder and severe pain. Radiographs of the shoulder demonstrated findings most consistent with an osteosarcoma. Given the lack of chemotherapeutic options, the patient's prognosis is poor. Owing to the risk of infection and blood loss with surgical reconstruction, palliative amputation would be an option for both resection of the tumor and pain control.
Figure 6AP and lateral radiographs of the right knee showing a distal femur parosteal osteosarcoma. AP radiograph of the right knee after resection and reconstruction.
Figure 7Clinical photographs demonstrating a large tumor involving the left wrist and forearm of a 2-year-old boy. Biopsy resulted in diagnosis of lipofibromatosis and he was treated with resection of the tumor.
Follow-up Form
| Patient name: | ||||||||||||||||||||||
| Medical record number: | ||||||||||||||||||||||
| Phone number: | ||||||||||||||||||||||
| Family/neighbor contacts: | ||||||||||||||||||||||
| Age: | ||||||||||||||||||||||
| Sex: | ||||||||||||||||||||||
| Diagnosis: | ||||||||||||||||||||||
| Date of initial visit: | ||||||||||||||||||||||
| Date of surgery: | ||||||||||||||||||||||
| Surgeons: | ||||||||||||||||||||||
| Anesthesiologist: | ||||||||||||||||||||||
| Type of anesthesia: | ||||||||||||||||||||||
| Surgery performed: | ||||||||||||||||||||||
| Tourniquet time: | ||||||||||||||||||||||
| Implants used: | ||||||||||||||||||||||
| Extra testing/costs/equipment: | ||||||||||||||||||||||
| Disposable equipment used: | ||||||||||||||||||||||
| Donations received: | ||||||||||||||||||||||
| Overall costs minus donations received: | ||||||||||||||||||||||
| Blood loss: | ||||||||||||||||||||||
| Was blood donated/by whom: | ||||||||||||||||||||||
| Was blood needed: | ||||||||||||||||||||||
| Margins status: | ||||||||||||||||||||||
| No. of days in the hospital: | ||||||||||||||||||||||
| Complications: | ||||||||||||||||||||||
| Follow-up schedule/testing required: | ||||||||||||||||||||||
| Functional score used/initial score: | ||||||||||||||||||||||
| Follow-up (mo): | 1.5 | 3 | 6 | 9 | 12 | 15 | 18 | 21 | 24 | 27 | 30 | |||||||||||
| Recurrence (yes/no) | ||||||||||||||||||||||
| Metastasis (yes/no) | ||||||||||||||||||||||
| Complications (yes/no) | ||||||||||||||||||||||
| Functional score | ||||||||||||||||||||||
| Follow-up (mo): | 33 | 36 | 39 | 42 | 45 | 48 | 51 | 54 | 57 | 60 | ||||||||||||
| Recurrence (yes/no) | ||||||||||||||||||||||
| Metastasis (yes/no) | ||||||||||||||||||||||
| Complications (yes/no) | ||||||||||||||||||||||
| Functional score | ||||||||||||||||||||||
| Complications in detail: | ||||||||||||||||||||||
| Comments: | ||||||||||||||||||||||